Singulair (Montelukast) Mega Study
Contents
Singulair (Montelukast)
Singulair (Montelukast)

Related

A
Count
A
Treatments
A
Effects
A
User Variables 2
A
Measurements 3

Tags

Singulair
Montelukast
Singulair (Montelukast)

Treatment Effectiveness

User reported effectiveness ratings Singulair (Montelukast) for various conditions.

Conditions Major Improvement Moderate Improvement Much Worse No Effect Worse Responses
Allergic Rhinitis (Hay Fever) 5% 41% 7% 41% 5% 41
Samter's Triad 0% 27% 9% 45% 18% 11

Below is the degree of change seen after Singulair (Montelukast) is higher than average.

Outcomes
of
Below is the change in the listed outcome after is higher than average.
Sort by Effect Size
Sort by Confidence
% Change from Baseline*
*
Change in the listed outcome after is higher than average.

Singulair (Montelukast) Info

Property Value
Variable Name Singulair (Montelukast)
Aggregation Method SUM
Analysis Performed At 2020-10-09
Duration of Action 21 days
Filling Value 0
Kurtosis 2.1388888888889
Mean 0.25 count
Median 0 count
Minimum Allowed Value 0 count
Number of Aggregate Predictors 0
Number of Aggregate Outcomes 0
Number of Measurements 3
Number of Measurements (including those generated by tagged, joined, or child variables) 3
Public true
Onset Delay 30 minutes
Standard Deviation 0.45226701686665
Unit Count
User Variables 2
Variable Category Treatments
Variable ID 95270
Variance 0.20454545454545